Active Ingredient: HYDRALAZINE HYDROCHLORIDE; RESERPINE
Proprietary Name: DRALSERP
Dosage Form; Route of Administration: TABLET; ORAL
Strength: 25MG;0.1MG
Reference Listed Drug: No
Reference Standard: No
TE Code:
Application Number: A084617
Product Number: 001
Approval Date: Approved Prior to Jan 1, 1982
Applicant Holder Full Name: SANDOZ INC
Marketing Status:
Discontinued
Patent and Exclusivity Information